SEARCH RESULTS

3 RESULTS

David Standaert on FDA Approves L-dopa Cocktail for Parkinson’s

COMMENT Novartis has recently received approval to market a new drug for Parkinson's disease, Stalevo. This is in fact a new formulation of several drugs which are currently on the market. Stalevo contains three different drugs in a single tablet: carbidopa ...

Current Filters

  • TYPE: Comment x
  • Commentator: Standaert, David x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE